The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes

Journal of Surgical Oncology

Volumn 99, Issue 6, 2009, Pages 343-350

  Lee, King Teh ^a,b   Lu, Yi Wei ^b   Wang, Shen Nien ^a   Chen, Hong Yaw ^c   Chuang, Shih Chang ^a   Chang, Wen Tsan ^a   Shi, Hon Yi ^b   Ker, Chen Guo ^a   Chiu, Herng Chia ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c Yuan's Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

ADULT; ARTICLE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL CHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER RESECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERIOPERATIVE COMPLICATION; PREOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; ADJUVANT THERAPY; AGED; ANALYSIS OF VARIANCE; BLOOD; CANCER STAGING; ECONOMICS; HEPATIC ARTERY; KAPLAN MEIER METHOD; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HEPATIC ARTERY; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 65449150982     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21248     Document Type: Article

References (40)

1. Bosch FX, Ribes J, Borras J: Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271-285. (Pubitemid 29488770)
2. Ario S, Yamaoka Y, Futagawa S, et al.: Results of surgical and nonsurgical treatment for small-size hepatocellular carcinoma: A retrospective and nationwide surgery in Japan. The liver cancer study group of Japan. Hepatology 2000;32:1224-1229.
3. Pichlmayr R, Ringe B, Bechstein WO, et al.: Approach to primary liver cancer. Recent results. Cancer Res 1989;110:65-73.
4. Tsuzuki T, Sugioka A, Ueda M, et al.: Hepatic resection for hepatocellular carcinoma. Surgery 1990;107:511-520.
5. MacIntosh EL, Mink GY: Hepatic resection in patients with cirrhosis and hepatocellular carcinoma. Surg Gynecol Obstect 1992;174:245-252.
6. Lo CM, Ngan H, Tso WK, et al.: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-1171.
7. Bismuth H, Morino M, Sherlock D: Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992;163:387-394. (Pubitemid 23065050)
8. Hsu HC, Wei TC, Tsang YM, et al.: Histological assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization. Cancer 1986;57:1184-1191.
9. Monden M, Okamura J, Sakon M: Significance of transcatheter chemoembolization combined with surgical resection for hepatocellular carcinomas. Cancer Chemother Pharmacol 1989;23:90-95. (Pubitemid 19073766)
10. Robinette CDR, Gardner CC, Thomas HA: Selective hepatic arterial embolization as an adjunct to hepatic resection. South Med L 1987;80:1302-1304.
11. Yu YQ, Xu DB, Zhou XD, et al.: Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 1993;71:62-65.
12. Paye F, Jagot P, Vilgrain V, et al.: Preoperative chemoembolization of hepatocellular carcinoma:Acomparative study. Arch Surg 1998;133:767-772.
13. Gerunda GE, Neri D, Merenda R, et al.: Role of transarterial chemoembolization before liver resection for hepatocellular carcinoma. Liver Transplantation 2000;6:619-626.
14. Martin R, Party P, Fong Y, et al.: Simultaneous liver and colorectal resection are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003;197:233-242.
15. Martin R, Jarnagin WR, Fong Y, et al.: The use of fresh plasma after major hepatic resection for colorectal metastasis: Is there a standard for transfusion? J Am Coll Surg 2003;196:402-409.
16. Chen XP, Qiu FZ, Wu ZD, et al.: Long-term outcome of resection of large hepatocellular carcinoma. Br J Surg 2006;93:600-606.
17. Wu CC, Cheng SB, Ho WM, et al.: Liver resection for hepatocellular carcinoma in patients with cirrhosis. Br J Surg 2005;92:348-355.
18. Sheen PC, Lee KT, Chen HY, et al.: Conservative hepatic resection for hepatocellular carcinoma of cirrhotic patients. Int Surg 1996;81:280-283.
19. Takayasu K, Arii S, Ikai I, et al.: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006;131:461-469.
20. Lee HS, Kim KM, Yoon JH, et al.: Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-Endemic area: A prospective cohort study. J Clin Oncol 2002;20:4459-4465.
21. Zhang Z, Liu Q, He J, et al.: The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 2000;89:2606-2612.
22. Majno PE, Adam R, Bismuth H, et al.: Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688-703.
23. Sugo H, Futagawa S, Beppu T, et al.: Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: Relation between postoperative course and the pattern of tumor recurrence. World J Surg 2003;27:1295-1299.
24. Chen XP, Hu DY, Zhang ZW, et al.: Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma. Dig Surg 2007;24:208-213.
25. Lu CD, Peng SY, Jiang XC, et al.: Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinoma: Retrospective analysis of 120 cases. World J Surg 1999;23:293-300.
26. Kaibori M, Tanigawa N, Matsui Y, et al.: Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction. Anticancer Res 2006;26:3685-3692.
27. Wu CC, Ho YZ, Ho WL, et al.: Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal. Br J Surg 1995;82:122-126.
28. Yamasaki S, Hasegawa H, Kinoshita H, et al.: A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 1996;87:206-211.
29. Harada T, Matsuo K, Inoue T, et al.: Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma. Ann Surg 1996;224:4-9.
30. Choi GH, Kim DH, Kang CM, et al.: Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma? World J Surg 2007;32:2370-2377.
31. Luo YQ, Wang Y, Chen H, et al.: Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma. Hepatobiliary Pancreatic Dis Int 2002;1:523-526.
32. Sasaki A, Iwashita Y, Shibata K, et al.: Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. EJSO 2006;32:773-779.
33. Huang YS, Chiang JH, Wu JC, et al.: Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: Predictive value of the monoethylglycinexylidide test. Am J Gastroenterol 2002;97:1223-1227.
34. Chan AO, Yuen MF, Hui CK, et al.: A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 2002;94:1747-1752.
35. Pelletir G, Ducreux M, Gay F, et al.: Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial. Group CHC. J Hepatol 1998;29:129-134.
36. Uchida M, Kohno H, Kubota H, et al.: Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma. World J Surg 1966;20:326-331.
37. Sugo H, Futagawa S, Beppu T, et al.: Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: Relation between postoperative course and the pattern of tumor recurrence. World J Surg 2003;27:1295-1299.
38. Huang J, He X, Lin X, et al.: Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma. Chin Med J 2000;113:446-448.
39. Kim YB, Park YN, Park C: Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization. Histopathology 2001;38:160-166. (Pubitemid 32193630)
40. Bruix J, Llovel JM, Castells A: Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized controlled trial in a single institution. Hepatology 1998;27:1578-1581. (Pubitemid 28264682)